Matthew Shields is EVP, Global Operations of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 9,989 shares of TEVA, which is worth approximately $169,912. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,206 shares (Ordinary Shares) at a price of $17.02 per share, resulting in proceeds of $105,626. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.99K
n/a 3M change
n/a 12M change
Total Value Held $169,912

Matthew Shields Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
SELL
Open market or private sale
$105,626 $17.02 p/Share
6,206 Reduced 38.32%
9,989 Ordinary Shares
Jun 03 2025
BUY
Exercise of conversion of derivative security
-
16,195 Added 50.0%
16,195 Ordinary Shares
MS

Matthew Shields

EVP, Global Operations
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA